SYNTHESIS OF PHOSPHONAMIDIC ANHYDRIDES
769
salt, and the reaction mixture was shaken until dissolution occurred. The mixture was
further irradiated at 180 W for 1 min. The progress of the reaction was monitored by
31P NMR until the signal of N, N-dipropyl methylphosphonochloridate disappeared. The
reaction mass was washed and extracted with n-pentane (4 × 25 mL), and the solvent was
evaporated to afford N,N-dipropyl-P-methylphosphonamidic anhydride. The product was
triturated with pentane to get analytical purity.
N,N-Dipropyl-P-methylphosphonamidic anhydride (4a). Anal. Calcd.
C14H34N2O3P2: C, 49.40; H, 10.07; N, 8.23. Found: C, 49.43; H, 10.05; N, 8.25. IR
(KBr): 694(P C), 971 (P O P), 1089, 1152 (P N C), 1237 (P O), 1434 (C N),
2885 (C H) cm−1; 1H NMR (400 MHz, CDCl3) : δ 0.88 (t, J = 7.3 Hz, 12H, CH3), 1.53
3
(m, J = 7.3 Hz, 8H, CH2), 1.67 (d, JP = 18.6 Hz, 6H, CH3), 2.98 (m, JP = 11.4
H
H
Hz, 8H, CH2); 13C NMR (100 MHz, CDCl3): δ 10.53 (CH3), 18.90 (CH2), 21.06 (JP
C
= 150.5 Hz, CH3), 46.50 (3JP = 5.5 Hz, CH2); GCMS (EI); m/z (%): 340 (4.46), 240
C
(78.57), 226 (20.53), 162 (41.07), 168 (22.32), 100 (100), 43 (19.64).
N,N-Dibutyl-P-methylphosphonamidic anhydride (4b). Anal. Calcd.
C18H42N2O3P2: C, 54.53; H, 10.68; N, 7.07. Found : C, 54.50; H, 10.65; N, 7.08. IR
(KBr): 698(P C), 970 (P O P), 1080, 1150 (P N C), 1235 (P O), 1435 (C N), 2889
1
(C H) cm−1; H NMR (400 MHz, CDCl3) : δ 0.93 (t, J = 7.2 Hz, 12H, CH3), 1.27 (m,
J = 7.2 Hz, 8H, CH2), 1.33 (m, J = 7.0 Hz, 8H, CH2), 1.63 (d, JP H = 18.6 Hz, 6H, CH3),
3.01 (m, 3JP = 11.4 Hz, 8H, CH2); 13C NMR (100 MHz, CDCl3): δ 10.35 (CH3),15.73
H
(CH2), 18.95 (CH2), 20.09 (JP C = 150.5 Hz, CH3), 44.67 (3JP C = 5.5 Hz,CH2); GCMS
(EI); m/z (%): 396 (4.46), 318 (6.25), 275 (100), 190 (74.10), 148 (38.28), 128 (74.10),
106 (22.32), 92 (31.25), 41 (24.10).
N,N-Dipropyl-P-isopropylphosphonamidic anhydride (4c). Anal. Calcd.
C18H42N2O3P2 : C, 54.53; H,10.68; N, 7.07. Found : C, 54.50; H,10.65; N 7.09. IR
(KBr): 696 (P C), 975 (P O P), 1088, 1153 (P N C), 1237 (P O), 1437 (C N),
2888 (C H) cm−1; 1H NMR (400 MHz, CDCl3) : δ 0.82 (t, J = 6.3 Hz, 12H, CH3), 1.10
(dd, 3JP = 21.4 Hz, 12H, CH3), 1.54 (m, J = 6.3 Hz, 8H, CH2), 2.05 (m, J P-H = 19.9
H
Hz, 2H, CH), 3.0 (m, 3JP = 11.3 Hz, 8H, CH2); 13C NMR (100 MHz, CDCl3): δ 10.23
H
(CH3), 15.97 (3JP = 10.0 Hz, CH3), 18.45 (CH2), 21.05 (JP-C = 144.3 Hz, CH), 44.56
C
(3JP C = 5.6 Hz, CH2); GCMS (EI); m/z (%): 396 (3.6), 353 (5.45), 296 (24.54), 254 (50),
224 (12.72), 190 (18.18),148 (25.45), 100 (100), 43 (23.63).
N,N-Dibutyl-P-isopropylphosphonamidic anhydride (4d). Anal. Calcd.
C22H50N2O3P2: C, 58.38; H,11.14; N, 6.19. Found: C, 58.35; H,11.15; N 6.20. IR (KBr):
705(P C), 978 (P O P), 1090, 1155 (P N C), 1235 (P O), 1435 (C N), 2887(C H)
cm−1; 1H NMR (400 MHz, CDCl3) : δ 0.75 (t, J = 6.4 Hz, 12H, CH3), 1.05 (dd, 3JP
=
H
21.4 Hz, 12H, CH3), 1.10 (m, J = 6.4 Hz, 8H, CH2), 1.52 (m, J = 6.5 Hz, 8H, CH2), 2.05
(m, JP H = 19.9 Hz, 2H, CH), 3.02 (m, 3JP H = 11.3 Hz, 8H, CH2); 13C NMR (100 MHz,
CDCl3): δ 9.98 (CH3), 14.36 (3JP = 10.0 Hz,CH3), 18.36 (CH2), 21.05 (JP = 144.2
C
Hz, CH), 23.06 (CH2), 46.50 (3JP-CC= 5.5 Hz, CH2); GCMS (EI); m/z (%): 452 (4.5), 409
(3.6), 324 (18.18), 282 (12.72), 176 (20.90), 141 (18.18),128 (100), 41 (10.35).
N,N-Diisobutyl-P-isopropylphosphonamidic anhydride (4e). Anal. Calcd.
C22H50N2O3P2 : C, 58.38; H,11.14; N, 6.19. Found: C, 58.35; H,11.15; N 6.20. IR (KBr):
698 (P C), 980 (P O P), 1090, 1150 (P N C), 1240 (P O), 1436 (C N), 2885 (C H)
cm−1; 1H NMR (400 MHz, CDCl3) : δ 0.80 (d, J = 6.5 Hz, 12H, CH3), 1.05 (dd, 3JP-H
=
21.4 Hz, 12H, CH3), 1.52 (m, J = 6.1Hz, 4H, CH), 2.05 (m, JP = 19.9 Hz, 2H, CH),
H
3.02 (m, 3JP = 11.3 Hz, 8H, CH2); 13C NMR (100 MHz, CDCl3): δ 9.98 (CH3), 14.36
H
(3JP C = 10.0 Hz,CH3), 19.56 (CH), 21.05 (JP C = 144.2 Hz, CH), 46.47 (3JP C = 5.5 Hz,